NKX2-3 is a homeodomain transcription factor that functions as a sequence-specific DNA-binding regulator of gene expression, primarily in endothelial cells and vascular tissues. Its primary physiological role involves specification and regulation of vascular development in tissue-specific contexts, particularly in the pancreatic islet microvasculature and intestinal vasculature 12. Mechanistically, NKX2-3 acts as a master regulator of endothelial gene programs: it promotes expression of permeability-regulating genes including PLVAP and controls angiogenic signaling through VEGF and endothelin-1 pathways 13. In tumor pericytes, NKX2-3 suppresses calcium influx via PDE1C/cAMP/PKA signaling, inducing vasodilation that facilitates metastatic dissemination 4. Clinically, NKX2-3 dysfunction is associated with multiple diseases. Genetic mutations in NKX2-3 cause idiopathic intestinal varicosis, linking its role in vascular development to human pathology 2. Polymorphisms in NKX2-3 confer susceptibility to inflammatory bowel disease through dysregulation of microvascular endothelial function 35. Overexpression of NKX2-3 drives marginal-zone lymphoma development via B-cell receptor signaling activation and enhanced B-cell homing 6, and aberrant NKX2-3 expression contributes to specific acute myeloid leukemia subtypes 7. NKX2-3 expression is reduced in colorectal carcinomas and correlates inversely with aging 5.